CLINICAL TRIALS AND OBSERVATIONS Clinical and immunologic outcome of patients with cartilage hair hypoplasia after hematopoietic stem cell transplantation

نویسندگان

  • Victoria Bordon
  • Andrew R. Gennery
  • Mary A. Slatter
  • Els Vandecruys
  • Genevieve Laureys
  • Paul Veys
  • Waseem Qasim
  • Wilhelm Friedrich
  • Nico M. Wulfraat
  • Franziska Scherer
  • Andrew J. Cant
  • Alain Fischer
  • Marina Cavazzana-Calvo
  • Robbert G. M. Bredius
  • Luigi D. Notarangelo
  • Evelina Mazzolari
  • Benedicte Neven
  • Tayfun Güngör
چکیده

1Pediatric Hematology, Oncology and Stem Cell Transplantation, Kliniek voor Kinderziekten C. Hooft, Ghent University Hospital, Ghent, Belgium; 2Newcastle University, Newcastle upon Tyne, United Kingdom; 3Departments of Bone Marrow Transplantation and Clinical Immunology, Great Ormond Street Hospital, London, United Kingdom; 4Universitätskinderklinik und Poliklinik, Ulm, Germany; 5Utrecht University Hospital, Utrecht, The Netherlands; 6Division of Immunology/Hematology/BMT, University Children’s Hospital, Zürich, Switzerland; 7Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Necker-Enfants Malades, Service d’Immuno-Hématologie Pédiatrique, Paris, France; 8AP-HP, Hôpital Necker-Enfants Malades, Service de Biotherapie, Paris, France; 9Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands; 10The Manton Center for Orphan Disease Research and Division of Immunology, Children’s Hospital, Boston, MA; and 11Oncology-Haematology Unit, Clinica Pediatrica, Spedali Civili, Brescia, Italy

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective treatment for selected hematological malignancies. Its curative potential is largely mediated by an immune-mediated destruction of malignant cells by donor lymphocytes termed graft-versus-leukemia (GVL) effect. However, because of its toxicity, conventional allogeneic HSCT is restricted to younger and fitter patient...

متن کامل

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS A long-term follow-up study on hepatitis B surface antigen–positive patients undergoing allogeneic hematopoietic stem cell transplantation

The long-term hepatic complications after allogeneic hematopoietic stem cell transplantation (HSCT) in hepatitis B virus (HBV) endemic area are unknown. We examined the serological and liverrelated outcome of 803 consecutive patients who received allogeneic HSCTs, with a median follow-up period of 83 months (range, 0.5-155 months). Late HBV-related hepatitis occurred in 2 of the 721 hepatitis B...

متن کامل

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

Autologous stem cell transplantation (ASCT) improves survival in patients with previously untreated multiple myeloma (MM) and relapsed, chemotherapy-sensitive, aggressive non-Hodgkin lymphoma (NHL). Lower relapse rates seen in allogeneic stem cell transplantation have been related to early absolute lymphocyte count (ALC) recovery as a manifestation of early graft-verus-tumor effect. In ASCT, th...

متن کامل

Regular Article CLINICAL TRIALS AND OBSERVATIONS Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Hochschule Hannover, Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation, Hannover, Germany; Department of Hematology, Hospital Universitario La Fe, Valencia University Medical School, Valencia, Spain; Stiftung Deutsche Klinik für Diagnostik GmbH, Zentrum für Blutstammzellund Knochenmarktransplantation, Wiesbaden, Germany; Klinikum der Johann Wolfgang Goethe Universi...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Improved outcome in central nervous system aspergillosis, using voriconazole treatment

The mortality of central nervous system (CNS) aspergillosis approaches 100%, requiring improved therapies. Voriconazole gives superior efficacy and survival in invasive aspergillosis, compared with amphotericin B. Also, in contrast to other antifungal drugs, voriconazole penetrates well into the CNS. We evaluated, retrospectively, the outcome and survival of 81 patients who were treated with vo...

متن کامل

ذخیره در منابع من

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2011